Clinical Trial Update: Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial evaluating leflunomide in combination with decitabine for relapsed or refractory myelodysplastic syndromes. The trial is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)
• Leflunomide (Leflunomide)

Snippet

Sponsor: West Virginia University | Conditions: Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: RECRUITING